A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors - Denys, D; de Geus, F; van Megen, H J (J Clin Psychiatry, 2004)
et al.